Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,548,826
-
Share change
-
-1,299,101
-
Total reported value
-
$3,111,000
-
Price per share
-
$0.68
-
Number of holders
-
37
-
Value change
-
-$1,797,962
-
Number of buys
-
11
-
Number of sells
-
26
Institutional Holders of ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) as of Q1 2016
As of 31 Mar 2016,
ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,548,826 shares.
The largest 10 holders included
BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Abingworth LLP, PANAGORA ASSET MANAGEMENT INC, BLACKROCK ADVISORS LLC, EAGLE GLOBAL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, Boxer Capital, LLC, and Ancora Advisors, LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.